Opportunities: Activated Partial Thromboplastin Time Test Market Scope by Demand, Trends to Expand Significantly by 2027

The global activated partial thromboplastin time test market forecast will surpass $601.2 million by the end of 2026, at a CAGR of 6.8%, and has been rising from $353.0 million in 2018, according to Activated Partial Thromboplastin Time Test Market Analysis by Research Dive.

Activated Partial Thromboplastin Time Test Market Trends: Rise in the prevalence of cardiovascular diseases coupled with increase in the demand for thromboplastin test instruments the key drivers for the growth of the activated partial thromboplastin time test market Increase in the adoption of thromboplastin test in the point-of-care diagnostic centers and improvements in the healthcare infrastructure are projected to drive the market growth. The improvements in healthcare infrastructure support the accessibility of test instruments and easy available of coagulation testing devices is anticipated to boost the activated partial thromboplastin time (APTT) test market growth. Furthermore, there is a rise in the blood disorders with increasing age of people across the globe; they require regular blood check-up to determine common and intrinsic pathways of blood coagulation. Due to wide usage of APTT test devices, the market is projected to grow in the coming years. Price of the treatment test coupled with dearth of skilled personal to perform APTT test are expected to hinder the growth of the market. Technological improvements in the activated partial thromboplastin time (APTT) testing instruments and key manufacturers concentrating on mergers & acquisitions to minimize the devices cost is anticipated to create ample investment opportunities in the activated partial thromboplastin time test market.

Instruments type segment will witness a noteworthy growth during the projected time. The growth is majorly because companies are increasing the R&D activities on diagnostic instruments to improve performance and accuracy of the instruments with low cost. The activated partial thromboplastin time test market for instruments product type is estimated to account for $289.8 million by 2026 at a 7.2% CAGR.

The market for point-of-care testing is projected to experience significant growth; it is anticipated to generate a revenue of $83.6 million by 2026 and is growing at a 7.7% CAGR. This growth is because of an increase in the number of point-of-care testing centers along with an increase in the population with age group above 60. The hospitals segment held the largest activated partial thromboplastin time test market size in 2018; it is estimated to reach $217.6 million by 2026, increasing at a growth rate of 6.5%. This is because of the growing usage of thromboplastin time test devices in the hospitals sector to treat patients for the analysis of hematological.

Asia-Pacific market will witness the highest growth rate of 7.3% CAGR and is expected to register a revenue of $143.1 million by 2026. This growth is attributed to swift progress in healthcare along with people preferring the point of care diagnosis of hospitals. Due to this swift growth, the Asia-Pacific market is predicted to grow during the forecast time. The global activated partial thromboplastin time test market was dominated by Europe, it was registered for majority of the activated partial thromboplastin market share, which was 30.0% in 2018. This growth is owing to the presence of upgraded diagnostic infrastructure in Europe. The market for North America region is expected to generate a revenue of $156.3 million by the end of 2026 with a CAGR of 6.7% during the projected time period.

Top gaining participants in the activated partial thromboplastin time test market are Bio-Rad Laboratories, Inc., ThermoFisher, Abbott, bioMérieux, Inc., Danaher, Hoffmann-La Roche Ltd, Beckman Coulter, Inc., Takara Bio Inc., HORIBA, Ltd., Ortho Clinical Diagnostics and Siemens Healthcare Private Limited. These participants are continuously increasing their efforts to improve the product performance and introducing new technologies to gain the largest market share in the overall activated partial thromboplastin time test industry.

Mr. Abhishek Paliwal
Research Dive
30 Wall St. 8th Floor, New York
NY 10005 (P)
+ 91 (788) 802-9103 (India)
+1 (917) 444-1262 (US) Toll
Free : +1 -888-961-4454
Email: support@researchdive.com
LinkedIn: https://www.linkedin.com/company/research-dive
Twitter: https://twitter.com/ResearchDive
Facebook: https://www.facebook.com/Research-Dive
Blog: https://www.researchdive.com/blog
Follow us on: https://covid-19-market-insights.blogspot.com

COVID-19 Impact: Which Are the Key Players Evolving In the Growth of Assisted Reproductive Technology Market?

The worldwide spread of COVID-19 has positively impacted the global assisted reproductive technology market . This is mainly due to supportive government policies and the strategic steps taken by major market players in the pandemic crisis. For instance, in June 2020, SART launched its fertility expert’s podcast series. Furthermore, the global market is expected to observe substantial growth even after the pandemic owing to the growing adoption of R&D and growing awareness amongst people regarding assisted reproductive technology. The global assisted reproductive technology market is likely to experience an increase in the growth rate during the COVID-19 pandemic. As per a new report added by Research Dive, the global assisted reproductive technology market is anticipated to reach up to $56.3 billion during the forecast period from 2019 to 2026. Comprehensive analysis on drivers, challenges, growth opportunities, major segments, and key strategies executed by maj...

Why Dynamics of Organ Care System Market for Liver Is Changing Drastically? What If History Is Any Guide?

The COVID-19 outbreak has helped the global organ care system market to grow at a positive rate. The manufactures of the industry are investing more in R&D activities to grow exponentially during the forecast period. The COVID-19 pandemic has positively impacted the global Organ care system (OCS) for liver market and a slight increase in the growth rate is observed from the previous predictions. As per new Research Dive published report, the global OCS for liver market is anticipated to grow at a CAGR of 9.3% by 2026, generating a revenue of $42.7 million in the period of forecast from 2019 to 2026. To better understand the pandemic effect on the global market, the report includes comprehensive analysis on growth opportunities, restraints, drivers, vital segments, and strategies adopted by major market players. For More Detail Insights, Download FREE Sample at: https://www.researchdive.com/download-sample/253 Highlights of the Report As per our analysts, the risi...

COVID-19 Impact: What Challenges Medical Tourism Market May See In Next 5 Years?

The COVID-19 crisis has affected the global medical tourism market in a negative way. The governments are taking initiatives to help patients seek healthcare treatment and the market is likely to recover by Q1/Q2 of 2022. The COVID-19 pandemic has hugely impacted the global medical tourism market and a slight downfall is witnessed in the growth rate as compared to the former predictions. As per new Research Dive published report, the global medical tourism market is anticipated to rise at a CAGR of 11.7% by 2026, generating a revenue of $142.2 billion in the period of forecast from 2019 to 2026. While there is a decrease in the growth rate due to the COVID-19 outbreak, the market is likely to recover by Q1/Q2 of 2022. For More Detail Insights, Download FREE Sample at : https://www.researchdive.com/download-sample/248 Highlights of the Report As per our analysts, the increasing interests amongst people coupled with technological advancements in healthcare treatment is...

MyTrade-Insights

Search This Blog